公司資料
Amicus Therapeutics 股價、新聞與催化劑
- 股票代碼:
- FOLD
- 交易所:
- NASDAQ
- 產業:
- Small Molecule Drugs
- 所在地:
- United States
股票表現
14.49 USD (+0.21%)
收盤價
最後更新: 2026年4月24日
—
市值
股價為何變動
目前無法取得 FOLD 的收盤價變動背景。
公司概覽
業務概覽
Amicus Therapeutics is a rare-disease company focused on Fabry and Pompe disease through commercial therapies and pipeline work.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Amicus sits in specialty biopharma.
商業模式特徵
The company combines orphan-drug commercialization with a pipeline that can extend the rare-disease franchise.
生技產業定位
Amicus occupies a durable rare-disease niche where commercial execution and label expansion matter more than broad pipeline breadth.
未來催化劑
- Amicus's catalysts are Pombiliti plus Opfolda commercial uptake and continued Galafold execution in Fabry disease. The company is trying to prove that its rare-disease platform can keep compounding beyond a single product cycle.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。